# Marinemax Inc: financial statements, quarterly

HZO · NYSE · CIK 1057060 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/hzo.md) · [Financials](/companies/hzo/financials.md) · [Filings](/companies/hzo/filings.md) · [Insiders](/companies/hzo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hzo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [595 d](/filings/0001193125-25-284680.md) | [527](/filings/0000950170-25-008305.md) | [583](/filings/0000950170-25-058103.md) | [758](/filings/0000950170-25-098321.md) | [563 d](/filings/0001193125-25-284680.md) | [468](/filings/0001193125-26-029291.md) | [632](/filings/0001193125-26-173623.md) | [657](/filings/0001193125-26-314062.md) | [552 d](/filings/0001193125-25-284680.md) | [505](/filings/0001193125-26-029291.md) | [527](/filings/0001193125-26-173623.md) | [611](/filings/0001193125-26-314062.md) |
| Cost of revenue | $m | [391 d](/filings/0001193125-25-284680.md) | [352](/filings/0000950170-25-008305.md) | [392](/filings/0000950170-25-058103.md) | [516](/filings/0000950170-25-098321.md) | [370 d](/filings/0001193125-25-284680.md) | [299](/filings/0001193125-26-029291.md) | [442](/filings/0001193125-26-173623.md) | [458](/filings/0001193125-26-314062.md) | [361 d](/filings/0001193125-25-284680.md) | [345](/filings/0001193125-26-029291.md) | [346](/filings/0001193125-26-173623.md) | [393](/filings/0001193125-26-314062.md) |
| Gross profit | $m | [204 d](/filings/0001193125-25-284680.md) | [175](/filings/0000950170-25-008305.md) | [190](/filings/0000950170-25-058103.md) | [242](/filings/0000950170-25-098321.md) | [193 d](/filings/0001193125-25-284680.md) | [170](/filings/0001193125-26-029291.md) | [190](/filings/0001193125-26-173623.md) | [200](/filings/0001193125-26-314062.md) | [191 d](/filings/0001193125-25-284680.md) | [160](/filings/0001193125-26-029291.md) | [181](/filings/0001193125-26-173623.md) | [218](/filings/0001193125-26-314062.md) |
| Selling, general and administrative | $m | [169 d](/filings/0001193125-25-284680.md) | [156](/filings/0000950170-25-008305.md) | [169](/filings/0000950170-25-058103.md) | [181](/filings/0000950170-25-098321.md) | [166 d](/filings/0001193125-25-284680.md) | [131](/filings/0001193125-26-029291.md) | [167](/filings/0001193125-26-173623.md) | [172](/filings/0001193125-26-314062.md) | [178 d](/filings/0001193125-25-284680.md) | [156](/filings/0001193125-26-029291.md) | [170](/filings/0001193125-26-173623.md) | [181](/filings/0001193125-26-314062.md) |
| Operating income | $m | [34.3 d](/filings/0001193125-25-284680.md) | [19.0](/filings/0000950170-25-008305.md) | [21.4](/filings/0000950170-25-058103.md) | [61.0](/filings/0000950170-25-098321.md) | [26.8 d](/filings/0001193125-25-284680.md) | [39.0](/filings/0001193125-26-029291.md) | [22.7](/filings/0001193125-26-173623.md) | [(41.5)](/filings/0001193125-26-314062.md) | [13.8 d](/filings/0001193125-25-284680.md) | [4.9](/filings/0001193125-26-029291.md) | [10.8](/filings/0001193125-26-173623.md) | [37.2](/filings/0001193125-26-314062.md) |
| Interest expense | $m | [15.8 d](/filings/0001193125-25-284680.md) | [18.4](/filings/0000950170-25-008305.md) | [19.4](/filings/0000950170-25-058103.md) | [18.2](/filings/0000950170-25-098321.md) | [17.9 d](/filings/0001193125-25-284680.md) | [18.7](/filings/0001193125-26-029291.md) | [18.2](/filings/0001193125-26-173623.md) | [16.9](/filings/0001193125-26-314062.md) | [17.3 d](/filings/0001193125-25-284680.md) | [15.9](/filings/0001193125-26-029291.md) | [14.7](/filings/0001193125-26-173623.md) | [14.3](/filings/0001193125-26-314062.md) |
| Income tax | $m | [3.3 d](/filings/0001193125-25-284680.md) | [(0.2)](/filings/0000950170-25-008305.md) | [0.6](/filings/0000950170-25-058103.md) | [11.1](/filings/0000950170-25-098321.md) | [4.1 d](/filings/0001193125-25-284680.md) | [2.1](/filings/0001193125-26-029291.md) | [1.4](/filings/0001193125-26-173623.md) | [(6.5)](/filings/0001193125-26-314062.md) | [(3.4) d](/filings/0001193125-25-284680.md) | [(2.8)](/filings/0001193125-26-029291.md) | [(1.1)](/filings/0001193125-26-173623.md) | [7.3](/filings/0001193125-26-314062.md) |
| Net income | $m | [15.1 d](/filings/0001193125-25-284680.md) | [0.9](/filings/0000950170-25-008305.md) | [1.6](/filings/0000950170-25-058103.md) | [31.6](/filings/0000950170-25-098321.md) | [4.0 d](/filings/0001193125-25-284680.md) | [18.1](/filings/0001193125-26-029291.md) | [3.3](/filings/0001193125-26-173623.md) | [(52.1)](/filings/0001193125-26-314062.md) | [(0.9) d](/filings/0001193125-25-284680.md) | [(7.9)](/filings/0001193125-26-029291.md) | [(2.6)](/filings/0001193125-26-173623.md) | [15.4](/filings/0001193125-26-314062.md) |
| Diluted EPS | $ per share | not reported | [0.04](/filings/0000950170-25-008305.md) | [0.07](/filings/0000950170-25-058103.md) | [1.37](/filings/0000950170-25-098321.md) | not reported | [0.77](/filings/0001193125-26-029291.md) | [0.14](/filings/0001193125-26-173623.md) | [(2.42)](/filings/0001193125-26-314062.md) | not reported | [(0.36)](/filings/0001193125-26-029291.md) | [(0.12)](/filings/0001193125-26-173623.md) | [0.66](/filings/0001193125-26-314062.md) |
| Basic EPS | $ per share | not reported | [0.04](/filings/0000950170-25-008305.md) | [0.07](/filings/0000950170-25-058103.md) | [1.42](/filings/0000950170-25-098321.md) | not reported | [0.80](/filings/0001193125-26-029291.md) | [0.15](/filings/0001193125-26-173623.md) | [(2.42)](/filings/0001193125-26-314062.md) | not reported | [(0.36)](/filings/0001193125-26-029291.md) | [(0.12)](/filings/0001193125-26-173623.md) | [0.70](/filings/0001193125-26-314062.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [201](/filings/0000950170-24-127036.md) | [210](/filings/0000950170-24-007382.md) | [217](/filings/0000950170-24-048260.md) | [242](/filings/0000950170-24-086479.md) | [224](/filings/0001193125-25-284680.md) | [145](/filings/0000950170-25-008305.md) | [204](/filings/0000950170-25-058103.md) | [151](/filings/0000950170-25-098321.md) | [170](/filings/0001193125-26-314062.md) | [165](/filings/0001193125-26-029291.md) | [189](/filings/0001193125-26-173623.md) | [175](/filings/0001193125-26-314062.md) |
| Current assets | $m | [1,123](/filings/0000950170-24-127036.md) | [1,206](/filings/0000950170-24-007382.md) | [1,293](/filings/0000950170-24-048260.md) | [1,261](/filings/0000950170-24-086479.md) | [1,273](/filings/0001193125-25-284680.md) | [1,298](/filings/0000950170-25-008305.md) | [1,324](/filings/0000950170-25-058103.md) | [1,198](/filings/0000950170-25-098321.md) | [1,181](/filings/0001193125-26-314062.md) | [1,144](/filings/0001193125-26-029291.md) | [1,161](/filings/0001193125-26-173623.md) | [1,087](/filings/0001193125-26-314062.md) |
| Total assets | $m | [2,421](/filings/0000950170-24-127036.md) | [2,527](/filings/0000950170-24-007382.md) | [2,631](/filings/0000950170-24-048260.md) | [2,594](/filings/0000950170-24-086479.md) | [2,605](/filings/0001193125-25-284680.md) | [2,634](/filings/0000950170-25-008305.md) | [2,673](/filings/0000950170-25-058103.md) | [2,488](/filings/0000950170-25-098321.md) | [2,470](/filings/0001193125-26-314062.md) | [2,428](/filings/0001193125-26-029291.md) | [2,442](/filings/0001193125-26-173623.md) | [2,358](/filings/0001193125-26-314062.md) |
| Current liabilities | $m | [847](/filings/0000950170-24-127036.md) | [940](/filings/0000950170-24-007382.md) | [1,046](/filings/0000950170-24-048260.md) | [1,054](/filings/0000950170-24-086479.md) | [1,069](/filings/0001193125-25-284680.md) | [1,091](/filings/0000950170-25-008305.md) | [1,139](/filings/0000950170-25-058103.md) | [991](/filings/0000950170-25-098321.md) | [985](/filings/0001193125-26-314062.md) | [961](/filings/0001193125-26-029291.md) | [983](/filings/0001193125-26-173623.md) | [881](/filings/0001193125-26-314062.md) |
| Total liabilities | $m | [1,503](/filings/0000950170-24-127036.md) | [1,592](/filings/0000950170-24-007382.md) | [1,691](/filings/0000950170-24-048260.md) | [1,617](/filings/0000950170-24-086479.md) | [1,619](/filings/0001193125-25-284680.md) | [1,631](/filings/0000950170-25-008305.md) | [1,670](/filings/0000950170-25-058103.md) | [1,536](/filings/0000950170-25-098321.md) | [1,522](/filings/0001193125-26-314062.md) | [1,484](/filings/0001193125-26-029291.md) | [1,498](/filings/0001193125-26-173623.md) | [1,394](/filings/0001193125-26-314062.md) |
| Long-term debt | $m | [389](/filings/0000950170-24-127036.md) | [381](/filings/0000950170-24-007382.md) | [373](/filings/0000950170-24-048260.md) | [364](/filings/0000950170-24-086479.md) | [356](/filings/0001193125-25-284680.md) | [347](/filings/0000950170-25-008305.md) | [339](/filings/0000950170-25-058103.md) | [365](/filings/0000950170-25-098321.md) | [356](/filings/0001193125-26-314062.md) | [347](/filings/0001193125-26-029291.md) | [339](/filings/0001193125-26-173623.md) | [335](/filings/0001193125-26-314062.md) |
| Current portion of debt | $m | [33.8](/filings/0000950170-24-127036.md) | [33.8](/filings/0000950170-24-007382.md) | [33.8](/filings/0000950170-24-048260.md) | [33.8](/filings/0000950170-24-086479.md) | [33.8](/filings/0001193125-25-284680.md) | [33.8](/filings/0000950170-25-008305.md) | [33.8](/filings/0000950170-25-058103.md) | [35.6](/filings/0000950170-25-098321.md) | [35.6](/filings/0001193125-26-314062.md) | [35.6](/filings/0001193125-26-029291.md) | [35.6](/filings/0001193125-26-173623.md) | [27.5](/filings/0001193125-26-314062.md) |
| Short-term borrowings | $m | [537](/filings/0000950170-24-127036.md) | [665](/filings/0000950170-24-007382.md) | [737](/filings/0000950170-24-048260.md) | [701](/filings/0000950170-24-086479.md) | [709](/filings/0001193125-25-284680.md) | [795](/filings/0000950170-25-008305.md) | [822](/filings/0000950170-25-058103.md) | [735](/filings/0000950170-25-098321.md) | [716](/filings/0001193125-26-314062.md) | [703](/filings/0001193125-26-029291.md) | [690](/filings/0001193125-26-173623.md) | [608](/filings/0001193125-26-314062.md) |
| Shareholders' equity | $m | [916](/filings/0000950170-24-127036.md) | [925](/filings/0000950170-24-007382.md) | [931](/filings/0000950170-24-048260.md) | [968](/filings/0000950170-24-086479.md) | [976](/filings/0001193125-25-284680.md) | [993](/filings/0000950170-25-008305.md) | [993](/filings/0000950170-25-058103.md) | [941](/filings/0000950170-25-098321.md) | [937](/filings/0001193125-26-314062.md) | [933](/filings/0001193125-26-029291.md) | [932](/filings/0001193125-26-173623.md) | [952](/filings/0001193125-26-314062.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(25.3) d](/filings/0001193125-25-284680.md) | [(89.1)](/filings/0000950170-25-008305.md) | [(22.1) d](/filings/0000950170-25-058103.md) | [86.3 d](/filings/0000950170-25-098321.md) | [(0.8) d](/filings/0001193125-25-284680.md) | [(146)](/filings/0001193125-26-029291.md) | [72.5 d](/filings/0001193125-26-173623.md) | [84.9 d](/filings/0001193125-26-314062.md) | [61.5 d](/filings/0001193125-25-284680.md) | [16.9](/filings/0001193125-26-029291.md) | [55.5 d](/filings/0001193125-26-173623.md) | [85.2 d](/filings/0001193125-26-314062.md) |
| Capital expenditure | $m | [16.6 d](/filings/0001193125-25-284680.md) | [13.3](/filings/0000950170-25-008305.md) | [15.2 d](/filings/0000950170-25-058103.md) | [15.2 d](/filings/0000950170-25-098321.md) | [16.7 d](/filings/0001193125-25-284680.md) | [18.3](/filings/0001193125-26-029291.md) | [12.7 d](/filings/0001193125-26-173623.md) | [16.4 d](/filings/0001193125-26-314062.md) | [13.5 d](/filings/0001193125-25-284680.md) | [8.5](/filings/0001193125-26-029291.md) | [11.0 d](/filings/0001193125-26-173623.md) | [8.0 d](/filings/0001193125-26-314062.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.2](/filings/0000950170-24-007382.md) | [22.3](/filings/0000950170-24-048260.md) | [22.4](/filings/0000950170-24-086479.md) | [22.8](/filings/0000950170-25-008305.md) | [23.0](/filings/0000950170-25-058103.md) | [23.0](/filings/0000950170-25-098321.md) | [23.4](/filings/0001193125-26-029291.md) | [23.3](/filings/0001193125-26-173623.md) | [21.5](/filings/0001193125-26-314062.md) | [21.9](/filings/0001193125-26-029291.md) | [22.0](/filings/0001193125-26-173623.md) | [23.2](/filings/0001193125-26-314062.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,086,746 at 2026-07-20, from the cover of the [10-Q filed 2026-07-23](/filings/0001193125-26-314062.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.